• 7732 Citations
  • 37 h-Index
1987 …2024
If you made any changes in Pure these will be visible here soon.

Research Outputs 1987 2019

Filter
Article
1987

A second Australian family with hemoglobin north shore (β134 val→glu)

Gurney, H., Baig, I., Gordon, S., Phadke, K., Kearsley, H., Fleming, P., Wyatt, K. & Hughes, W., 1987, In : Pathology. 19, 1, p. 62-63 2 p.

Research output: Contribution to journalArticleResearchpeer-review

Hemoglobins
Hemoglobin A2
Reticulocytosis
Hemoglobin A
2-Propanol
1989

Bone metastases in hypernephroma. Frequency of scapular involvement

Gurney, H., Larcos, G., McKay, M., Kefford, R. & Langlands, A., 1989, In : Cancer. 64, 7, p. 1429-1431 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Neoplasm Metastasis
Bone and Bones
Scapula
Pain

Recurrent transitional cell carcinoma of the renal pelvis presenting as diabetes insipidus

Gurney, H. P. & Page, J., 1989, In : European Journal of Surgical Oncology. 15, 3, p. 282-284 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Deamino Arginine Vasopressin
Diabetes Insipidus
Kidney Pelvis
Transitional Cell Carcinoma
Pituitary Gland

Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy

Gurney, H., Kefford, R. & Stuart-Harris, R., 29 Jul 1989, In : The Lancet. 334, 8657, p. 241-244 4 p.

Research output: Contribution to journalArticleResearchpeer-review

pamidronate
Phosphates
Kidney
Calcium
Hypercalcemia
1990

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma

Gurney, H., Crowther, D., Anderson, H., Murphy, D., Prendiville, J., Ranson, M., Mayor, P., Swindell, R., Buckley, C. H. & Tindall, V. R., 1990, In : Annals of Oncology. 1, 6, p. 427-433 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Carboplatin
Cyclophosphamide
Cisplatin
Carcinoma
Poisons

Original article: Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma

Gurney, H., Crowther, D., Anderson, H., Murphy, D., Prendiville, J., Ranson, M., Mayor, P., Swindell, R., Buckley, C. H. & Tindall, V. R., Nov 1990, In : Annals of Oncology. 1, 6, p. 423-433 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Carboplatin
Cyclophosphamide
Cisplatin
Carcinoma
Poisons

The management of primary fallopian tube carcinoma

Gurney, H., Murphy, D. & Crowther, D., 1990, In : British Journal of Obstetrics and Gynaecology. 97, 9, p. 822-826 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Fallopian Tubes
Carcinoma
Drug Therapy
Radiotherapy
Recurrence
1991

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer

Lind, M. J., Gomm, S., Simmonds, A. P., Ashcroft, L., Kamthan, A., Gurney, H. & Thatcher, N., Mar 1991, In : Cancer Chemotherapy and Pharmacology. 28, 2, p. 142-144 3 p.

Research output: Contribution to journalArticleResearchpeer-review

interferon alfa-2b
Ifosfamide
Non-Small Cell Lung Carcinoma
Interferons
Toxicity

Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer

Gurney, H., de Campos, E. S., Dodwell, D., Kamthan, A. & Thatcher, N., 1991, In : European Journal of Cancer and Clinical Oncology. 27, 5, p. 565-567 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Ifosfamide
Mitomycin
Non-Small Cell Lung Carcinoma
Karnofsky Performance Status
Therapeutics

The use of L-dopa and carbidopa in metastatic malignant melanoma

Gurney, H., Coates, A. & Kefford, R., Jan 1991, In : Journal of Investigative Dermatology. 96, 1, p. 85-87 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Carbidopa
Levodopa
Melanoma
Maximum Tolerated Dose
Toxicity
1992

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Pettengell, R., Gurney, H., Radford, J. A., Deakin, D. P., James, R., Wilkinson, P. M., Kane, K., Bentley, J. & Crowther, D., 1992, In : Blood. 80, 6, p. 1430-1436 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Granulocyte Colony-Stimulating Factor
Neutropenia
Non-Hodgkin's Lymphoma
Randomized Controlled Trials
Chemotherapy

Haemopoietic cell kinetics in humans treated with rGM‐CSF

Lord, B. I., Gurney, H., Chang, J., Thatcher, N., Crowther, D. & Dexter, T. M., 1992, In : International Journal of Cancer. 50, 1, p. 26-31 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Bone Marrow
Granulocyte-Macrophage Colony-Stimulating Factor
Granulocytes
Small Cell Lung Carcinoma
Eosinophilia

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

Gurney, H., Anderson, H., Radford, J., Potter, M. R., Swindell, R., Steward, W., Kamthan, A., Chang, J., Weiner, J., Thatcher, N. & Crowther, D., 1992, In : European Journal of Cancer. 28, 1, p. 105-112 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Small Cell Lung Carcinoma
Granulocyte-Macrophage Colony-Stimulating Factor
Drug Therapy
Infection
Neutropenia
1993

A cost-utility approach to the use of 5-fluorouracil and levamisole ad adjuvant chemotherapy for Dukes' C colonic carcinoma

Smith, R. D., Hall, J., Gurney, H. & Harnett, P. R., 1993, In : Medical Journal of Australia. 158, 5, p. 319-320 2 p.

Research output: Contribution to journalArticleResearchpeer-review

Levamisole
Adjuvant Chemotherapy
Fluorouracil
Carcinoma
Costs and Cost Analysis

Hypercalcaemia in small cell lung cancer: Report of a case associated with parathyroid hormone-related protein (PTHrP)

Stuart-Harris, R., Ahern, V., Danks, J. A., Gurney, H. & Martin, T. J., 1993, In : European Journal of Cancer. 29, 11, p. 1601-1604 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Parathyroid Hormone-Related Protein
Small Cell Lung Carcinoma
Hypercalcemia
Parathyroid Hormone Receptor Type 1
Neoplasms

Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia

Gurney, H., Grill, V. & Martin, T. J., 26 Jun 1993, In : The Lancet. 341, 8861, p. 1611-1613 3 p.

Research output: Contribution to journalArticleResearchpeer-review

pamidronate
Parathyroid Hormone-Related Protein
Hypercalcemia
Neoplasms
Albumins
1995

Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer

Gurney, H., Harnett, P., Stuart-Harris, R. & Kefford, R., 1995, In : European Journal of Cancer. 31, 11, p. 1773-1777 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Epirubicin
Ifosfamide
Vincristine
Breast Neoplasms
Mesna
1997

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results

Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : Seminars in Oncology. 24, 5 SUPPL. 17, p. S17-5-S17-9 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Prednisone
Paclitaxel
Methotrexate
Fluorouracil
Cyclophosphamide

Paclitaxel as first-line treatment for metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Tattersall, M. H., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : ONCOLOGY. 11, 4 SUPPL. 3, p. 19-23 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Paclitaxel
Breast Neoplasms
Therapeutics
Quality of Life
Cyclophosphamide
1998

Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation

Gurney, H. P., Ackland, S., Gebski, V. & Farrell, G., Jul 1998, In : Journal of Clinical Oncology. 16, 7, p. 2299-2304 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Epirubicin
Body Surface Area
Pharmacokinetics
Neutropenia
Antipyrine
Inflammatory Breast Neoplasms
Epirubicin
Ifosfamide
Vincristine
Radiotherapy

Skull metastases masquerading as cerebral secondaries in patients with cancer

Wright, J., Gurney, H. & Glare, P., 1998, In : Australian and New Zealand Journal of Medicine. 28, 1, p. 62 1 p.

Research output: Contribution to journalArticleResearchpeer-review

1999

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J., Stephenson, J. & Canetta, R., Aug 1999, In : Journal of Clinical Oncology. 17, 8, p. 2355-2364 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Paclitaxel
Combination Drug Therapy
Breast Neoplasms
Therapeutics
Infection

Long-term follow-up of patients treated with intermittent hormone therapy for advanced prostate cancer

Hruby, G., Gurney, H., Turner, S., Berry, M., Harnett, P. & Gebski, V., May 1999, In : Prostate Journal. 1, 3, p. 138-143 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Hormones
Therapeutics
Goserelin
Androgen Antagonists
2000

A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Rischin, D., Smith, J., Millward, M., Lewis, C., Boyer, M., Richardson, G., Toner, G., Gurney, H. & McKendrick, J., 2000, In : British Journal of Cancer. 83, 4, p. 438-442 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Epirubicin
Paclitaxel
Breast Neoplasms
Stroke Volume
Febrile Neutropenia

Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

King, M. T., Hall, J., Caleo, S., Gurney, H. P. & Harnett, P. R., 2000, In : International Journal of Health Services. 30, 3, p. 557-579 23 p.

Research output: Contribution to journalArticleResearchpeer-review

Costs and Cost Analysis
Drug Therapy
Home Care Services
Nurses
Urban Hospitals
2001

Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features

Shannon, C., Crombie, C., Brooks, A., Lau, H., Drummond, M. & Gurney, H., 2001, In : Annals of Oncology. 12, 7, p. 947-952 6 p.

Research output: Contribution to journalArticleResearchpeer-review

gemcitabine
Urothelium
Transitional Cell Carcinoma
Carboplatin
Therapeutics
2002

How to calculate the dose of chemotherapy

Gurney, H., 22 Apr 2002, In : British Journal of Cancer. 86, 8, p. 1297-1302 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Body Surface Area
Drug Therapy
Pharmaceutical Preparations
Guidelines
Testicular Neoplasms

Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma

Motzer, R. J., Rakhit, A., Thompson, J., Gurney, H., Selby, P., Figlin, R., Negrier, S., Ernst, S., Siebels, M., Ginsberg, M., Rittweger, K. & Hooftman, L., 1 Nov 2002, In : Annals of Oncology. 13, 11, p. 1799-1805 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Interferons
Asthenia
Subcutaneous Injections
Transaminases

α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma

Wong, M., Goldstein, D., Woo, H., Testa, G. & Gurney, H., 2002, In : Internal Medicine Journal. 32, 4, p. 158-162 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Isotretinoin
NSC 153174
Renal Cell Carcinoma
Interferon-alpha
Tretinoin
2004

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy

Wong, M., Balleine, R. L., Collins, M., Liddle, C., Clarke, C. L. & Gurney, H., Jun 2004, In : Clinical Pharmacology and Therapeutics. 75, 6, p. 529-538 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytochrome P-450 CYP3A
Midazolam
Genotype
Drug Therapy
Single Nucleotide Polymorphism
2005

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer

Wong, M., Evans, S., Rivory, L. P., Hoskins, J. M., Mann, G. J., Farlow, D., Clarke, C. L., Balleine, R. L. & Gurney, H., Jan 2005, In : Clinical Pharmacology and Therapeutics. 77, 1, p. 33-42 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Technetium Tc 99m Sestamibi
P-Glycoprotein
Single Nucleotide Polymorphism
Genotype
Liver
2006

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S. & McCaul, K., May 2006, In : European Journal of Cancer. 42, 8, p. 1083-1092 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Androgens
Prostatic Neoplasms
Quality of Life
Testosterone
Therapeutics

Maintaining bone health in patients with prostate cancer

Holmes-Walker, J., Woo, H., Gurney, H., Do, V. T. & Chipps, D. R., 20 Feb 2006, In : Medical Journal of Australia. 184, 4, p. 176-179 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Bone and Bones
Androgens
Health
Bone Density

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer

Wong, M., Balleine, R. L., Blair, E. Y. L., McLachlan, A. J., Ackland, S. P., Garg, M. B., Evans, S., Farlow, D., Collins, M., Rivory, L. P., Hoskins, J. M., Mann, G. J., Clarke, C. L. & Gurney, H., 1 Jun 2006, In : Journal of Clinical Oncology. 24, 16, p. 2448-2455 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Pharmacokinetics
Neoplasms
Cytochrome P-450 CYP3A
Neutrophils
Body Surface Area
2007

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype

Gurney, H., Wong, M., Balleine, R. L., Rivory, L. P., McLachlan, A. J., Hoskins, J. M., Wilcken, N., Clarke, C. L., Mann, G. J., Collins, M., Delforce, S. E., Lynch, K. & Schran, H., 14 Jul 2007, In : Clinical Pharmacology and Therapeutics. 82, 1, p. 33-40 8 p.

Research output: Contribution to journalArticleResearchpeer-review

P-Glycoprotein
Genotype
Cytochrome P-450 CYP3A
Gastrointestinal Stromal Tumors
Homozygote
2008

Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?

Chang, D. K., Merrett, N. D., Biankin, A. V. & NSW Pancreatic Cancer Network, Jul 2008, In : Journal of Gastroenterology and Hepatology (Australia). 23, 7 Pt 1, p. 1036-45 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Pancreatectomy
Mortality
Group Psychotherapy
Survival

Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: An effect of improved systemic therapy?

Lin, C., Turner, S., Gurney, H. & Peduto, A., Aug 2008, In : Journal of Medical Imaging and Radiation Oncology. 52, 4, p. 376-381 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Hormones
Neoplasm Metastasis
Therapeutics
Natural History

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand

Bell, D., Grimes, D., Gurney, H., Dalley, D., Blackwell, T., Fox, R. & Jeffery, M., Oct 2008, In : Internal Medicine Journal. 38, 10, p. 751-757 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Epoetin Alfa
New Zealand
Drug Therapy
Reticulocytes
Erythropoietin
2009

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer

Pezaro, C., Rosenthal, M. A., Gurney, H., Davis, I. D., Underhill, C., Boyer, M. J., Kotasek, D., Solomon, B. & Toner, G. C., Aug 2009, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 32, 4, p. 338-341 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Castration
Prostatic Neoplasms
Prostate-Specific Antigen
gefitinib
Epidermal Growth Factor Receptor
2010

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: Updated analysis of a randomized trial

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., Lewis, C. R., Levi, J. A., Boyer, M. J., Gurney, H., Craft, P., Boland, A. L., Simes, R. J. & Toner, G. C., 18 Aug 2010, In : Journal of the National Cancer Institute. 102, 16, p. 1253-1262 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Germ Cell and Embryonal Neoplasms
Bleomycin
Etoposide
Drug Therapy
Cisplatin

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

Nath, C. E., Shaw, P. J., Trotman, J., Zeng, L., Duffull, S. B., Hegarty, G., McLachlan, A. J., Gurney, H., Kerridge, I., Kwan, Y. L., Presgrave, P., Tiley, C., Joshua, D. & Earl, J., May 2010, In : British Journal of Clinical Pharmacology. 69, 5, p. 484-497 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Melphalan
Multiple Myeloma
Pharmacokinetics
Population
Area Under Curve
2011

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Lee, C. K., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R. J. & Friedlander, M., 26 Jul 2011, In : British Journal of Cancer. 105, 3, p. 360-365 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Carboplatin
Leukopenia
Paclitaxel
Ovarian Neoplasms
Disease-Free Survival

Environmental and genetic factors affecting transport of imatinib by OATP1A2

Eechoute, K., Franke, R. M., Loos, W. J., Scherkenbach, L. A., Boere, I., Verweij, J., Gurney, H., Kim, R. B., Tirona, R. G., Mathijssen, R. H. J. & Sparreboom, A., 2011, In : Clinical Pharmacology and Therapeutics. 89, 6, p. 816-820 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Interactions
Duodenum
Biological Availability
Anions
Peptides

Paraneoplastic hepatic dysfunction in metastatic prostate cancer: the role of cytokine dysregulation

Nguyen, V., Gurney, H. & Van Der Poorten, D., 10 Jan 2011, In : Journal of Clinical Oncology. 29, 2, p. 1-3 3 p.

Research output: Contribution to journalArticleResearchpeer-review

2013

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Single Nucleotide Polymorphism
Biotinylation
Molecular Models
Membranes
HEK293 Cells

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 2013, In : Journal of Translational Medicine. 11, p. 189 1 p.

Research output: Contribution to journalArticleResearchpeer-review

Chemotherapy
Neutropenia
Non-Small Cell Lung Carcinoma
Ovarian Neoplasms
Neutrophils

Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer

Won, A. C. M., Gurney, H., Marx, G., De Souza, P. & Patel, M. I., Aug 2013, In : BJU international. 112, 4, p. E250-E255 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostate
Prostatic Neoplasms
Prostatectomy
Radiotherapy
Therapeutics

The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study

Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G. C., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., Alam, M., Cox, K. & Olver, I., Nov 2013, In : Psycho-Oncology. 22, 11, p. 2557-2564 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Testicular Neoplasms
Survivors
Cross-Sectional Studies
Psychology
Survival Rate
2014

Accelerated BEP for metastatic germ cell tumours: A multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. & Toner, G. C., 2014, In : Annals of Oncology. 25, 1, p. 143-148 6 p., mdt369.

Research output: Contribution to journalArticleResearchpeer-review

Urogenital Neoplasms
Germ Cell and Embryonal Neoplasms
Bleomycin
Etoposide
New Zealand